RARα1/RARα2-PML mRNA expression in acute promyelocytic leukemia cells: A molecular and laboratory-clinical correlative study

Blood

Volumn 90, Issue 1, 1997, Pages 306-312

  Li, Yun Ping ^b   Andersen, Janet ^b   Zelent, Arthur ^b   Rao, Sreenivas ^b   Paietta, Elisabeth ^b   Tallman, Martin S ^b   Wiernik, Peter H ^b   Gallagher, Robert E ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RETINOIC ACID; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 15; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PROMYELOCYTIC LEUKEMIA;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0030612468     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.306.306_306_312     Document Type: Article

References (21)

1. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
2. Kakizuka A, Miller WH Jr, Umesono K, Warrell RP Jr, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
3. Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
4. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaub M-P, Chambon P, Pelicci PG: Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J 11:1397, 1992
5. Chen S-J, Chen Z, Chen A, Tong J-H, Dong S, Wang Z-Y, Waxman S, Zelent A: Occurrence of distinct PML-RARα fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction. Oncogene 7:1223, 1992
6. Alcalay M, Zangrilli D, Fagioli M, Pandolfi P, Mencarelli A, Lo Coco F, Biondi A, Grignani F, Pelicci P: Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:4840, 1992
7. Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T, Dube I, Winfield DA, Kingston J, Hagemeijer A, Rees JKH, Lister TA, Solomon E: Diagnosis of acute promyelocytic leukaemia by RT-PCR detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol 82:529, 1992
8. Fagioli M, Alcalay M, Pandolfi P, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci P: Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7:1083, 1992
9. Yoshida H, Naoe T, Fukutani F, Kiyoi H, Kubo K, Ohno R: Analysis of the joining sequences of the t(15; 17) translocation human acute promyelocytic leukemia: Sequence non-specific recombination between the PML and RARA genes within identical short sequences. Genes Chromosom Cancer 12:37, 1995
10. Lafage-Pochitaloff M, Alcalay M, Brunel V, Longo L, Sainty D, Simonetti J, Birg F, Pellici P: Acute promyelocytic leukemia cases with nonreciprocal PML/RARα or RARα/PML fusion genes. Blood 85:1169, 1995
11. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier J-M, Kastner P, Dierich A, Chambon P: Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid. EMBO J 10:59, 1991
12. Gallagher RE, Li Y-P, Rao S, Paietta E, Andersen J, Etkind P, Tallman MS, Wiernik PH: Characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: Identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 86:1540, 1995
13. Tallman MS, Andersen J, Schiffer CA, Appelbaum FR, Feusner JE, Woods WG, Ogden A, Weinstein H, Shepherd L, Rowe JM, Wiernik PH: Phase III randomized study of all-trans retinoic acid (ATRA) versus daunorubicin (D) as induction therapy and ATRA versus observation as maintenance therapy for patients with previously untreated acute promyelocytic leukemia. Blood 86:125a, 1995 (abstr, suppl 1)
14. Li Y-P, Said F, Gallagher R: Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-alpha. Blood 83:3298, 1994
15. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik P: The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study. Leukemia 8:1108, 1994
16. Mehta CR, Patel NR, Tsiatis AA: Exact significance testing to establish treatment equivalence with ordered categorical data. Biometrics 40:819, 1984
17. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
19. Cunningham I, Gee TS, Reich LM, Kempin SJ, Naval AN, Clarkson BD: Acute promyelocytic leukemia: Treatment results during a decade at Memorial Hospital. Blood 73:1116, 1989
20. Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M, Spier C, Hanson C, Bitter M, Braziel R, Mills G, Welborn J, Williams W, Hewlett J, Willman C, Appelbaum F: Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood 86:1717, 1995
21. Melo J, Hochhaus A, Yan X-H, Goldman J: Lack of correlation between ABL-BCR expression and response to interferon-α in chronic myelogenous leukaemia. Br J Haematol 92:684, 1996